TY - JOUR
T1 - The incidence of gastrointestinal pathology and subsequent anemia in young men presenting with iron deficiency without anemia
AU - Carter, Dan
AU - Bardan, Eytan
AU - Derazne, Estela
AU - Tzur, Dorit
AU - Avidan, Benjamin
N1 - Publisher Copyright:
© 2016 Wolters Kluwer Health, Inc.
PY - 2016
Y1 - 2016
N2 - Background and aims The etiology of iron deficiency (ID) without anemia in young men is unclear, and there are no evidencebased recommendations for the required gastrointestinal (GI) evaluation. The aims of this study were to examine the incidence of significant GI pathology and the development of anemia during the follow-up of young men presenting with ID, but without anemia. Methods All young men (18-30 years) who served in the Israel Defense Forces during the years 2005-2013 and had at least a single laboratory test indicative of ID without anemia were followed until the diagnosis of significant GI pathology or discharge from military service. Results The study population included 2061 young men (mean age 20.7 ± 1.8). During follow-up of 3150 person years, significant GI pathologies were diagnosed in 39 patients: Inflammatory bowel disease in 25 (1.2%), celiac disease in 8 (0.4%), and peptic disease in 4 (0.1%). No cases of GI-related cancer were diagnosed. ID anemia developed during follow-up in 203 (9.8%). Lower baseline hemoglobin levels, lower ferritin levels, and younger age at diagnosis were more common among those who developed anemia. The development of anemia was a predisposing factor for the diagnosis of GI pathology (risk ratio =3.60, 95% confidence interval 1.34-8.32, P= 0.012). Conclusion Significant GI pathology is very uncommon in young men presenting with ID. Overt anemia developed in close to 10% of the study cohort. Therefore, we advise simple GI evaluation (celiac serology, C-reactive protein or fecal calprotectin, and urease breath test) as well as follow-up in this population.
AB - Background and aims The etiology of iron deficiency (ID) without anemia in young men is unclear, and there are no evidencebased recommendations for the required gastrointestinal (GI) evaluation. The aims of this study were to examine the incidence of significant GI pathology and the development of anemia during the follow-up of young men presenting with ID, but without anemia. Methods All young men (18-30 years) who served in the Israel Defense Forces during the years 2005-2013 and had at least a single laboratory test indicative of ID without anemia were followed until the diagnosis of significant GI pathology or discharge from military service. Results The study population included 2061 young men (mean age 20.7 ± 1.8). During follow-up of 3150 person years, significant GI pathologies were diagnosed in 39 patients: Inflammatory bowel disease in 25 (1.2%), celiac disease in 8 (0.4%), and peptic disease in 4 (0.1%). No cases of GI-related cancer were diagnosed. ID anemia developed during follow-up in 203 (9.8%). Lower baseline hemoglobin levels, lower ferritin levels, and younger age at diagnosis were more common among those who developed anemia. The development of anemia was a predisposing factor for the diagnosis of GI pathology (risk ratio =3.60, 95% confidence interval 1.34-8.32, P= 0.012). Conclusion Significant GI pathology is very uncommon in young men presenting with ID. Overt anemia developed in close to 10% of the study cohort. Therefore, we advise simple GI evaluation (celiac serology, C-reactive protein or fecal calprotectin, and urease breath test) as well as follow-up in this population.
KW - anemia
KW - celiac disease
KW - inflammatory bowel disease
KW - iron deficiency
KW - peptic disease
UR - http://www.scopus.com/inward/record.url?scp=84976262174&partnerID=8YFLogxK
U2 - 10.1097/MEG.0000000000000687
DO - 10.1097/MEG.0000000000000687
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27337098
AN - SCOPUS:84976262174
SN - 0954-691X
VL - 28
SP - 1126
EP - 1129
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
IS - 10
ER -